Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine

Biochemical and Biophysical Research Communications

Volumn 294, Issue 2, 2002, Pages 429-440

  Hazeki, Noriko ^a,b,f   Tsukamoto, Tadashi ^a,b   Yazawa, Ikuru ^c   Koyama, Minami ^a,d   Hattori, Shunji ^e   Someki, Iori ^e   Iwatsubo, Takeshi ^a,d   Nakamura, Koichiro ^b   Goto, Jun ^a,b   Kanazawa, Ichiro ^a,b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NIPPI RESEARCH INSTITUTE OF BIOMATRIX   (Japan)

^f SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Aggregate; Heterogeneous nuclear ribonucleoproteins; Histone; Huntington's disease; Polyglutamine; Ubiquitin

Indexed keywords

GREEN FLUORESCENT PROTEIN; HISTONE; HYBRID PROTEIN; POLYGLUTAMINE; RIBONUCLEOPROTEIN; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN; CELL FUNCTION; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CENTRIFUGATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; EXON; FIBER; FLUORESCENCE ACTIVATED CELL SORTING; FRACTIONATION; HEAT TREATMENT; HUNTINGTON CHOREA; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; ULTRASTRUCTURE;

AMINO ACIDS; ANIMALS; CELL LINE; CELL NUCLEUS; CELL NUCLEUS STRUCTURES; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HISTONES; HUMANS; HUNTINGTON DISEASE; LUMINESCENT PROTEINS; MACROMOLECULAR SUBSTANCES; MICE; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RIBONUCLEOPROTEINS; TRANSFECTION; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITIN;

EID: 18444371744     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00498-9     Document Type: Article

References (34)

1. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
2. Intracellular inclusions pathological markers in diseases caused by expanded polyglutamine tracts?
3. The genetic defect causing Huntington's disease: Repeated in other contexts?
4. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
5. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
6. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
7. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA
8. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
9. Rapid aggregate formation of N-terminal huntingtin fragments carrying expanded polyglutamine tracts
10. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
11. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
12. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins proteasome components and SCR-1 and are suppressed by the HDJ-2 chaperone
13. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression
14. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
15. Self-assembly of polyglutamine containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
16. Nuclear import can be separated into distinct steps in vitro: Nuclear pore binding and translocation
17. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease
18. Analysis of matrix protein components of the dermis-like structure formed in a long-term culture of human fibroblasts: Type VI collagen is a major component
19. Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels
20. Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: Applying to quantification of protein components of the aggregates
21. Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
22. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy
23. Hnrnp proteins and the biogenesis of mRNA
24. A new view of mRNA export: Separating the wheat from the chaff
25. HnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells
26. Interaction between the human nuclear cap-binding protein complex and hnRNP F
27. SMN interacts with a novel family of hnRNP and spliceosomal proteins
28. Specific interaction of Smn the spinal muscular atrophy determining gene product with hnRNP-R and gry-rbp/hnRNP-Q: A role for Smn in RNA processing in motor axons?
29. Chromatin as an essential part of the transcriptional mechanism
30. The language of covalent histone modifications
31. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophilla
32. Altered transcription in yeast expressing expanded polyglutamine
33. Histone deacethylase inhibitors reduce polyglutamine toxicity
34. The ubiquitin-proteasome proteolytic pathway